[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100117941":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":12,"centralContacts":17,"locations":26,"responsibleParty":48,"collaborators":10,"id":50,"slug":51,"hasResults":52,"nctId":53,"briefTitle":54,"officialTitle":54,"acronym":10,"eligibilityCriteria":55,"healthyVolunteers":56,"sex":57,"minAge":58,"maxAge":10,"enrollmentInfo":59,"targetDuration":10,"studyType":62,"phases":10,"briefSummary":63,"conditions":64,"keywords":67,"overallStatus":29,"whyStopped":10,"lastUpdateSubmitDate":71,"lastUpdatePostDateStruct":72,"startDateStruct":75,"completionDateStruct":77,"leadSponsor":79,"locationsCount":60},{"fullName":5,"class":6},"Hadassah Medical Organization","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"Pre-existing Fibroblast MCB",null,"Pre-existing fibroblast donors for hESC derivation project",[13],{"name":14,"affiliation":15,"role":16},"Benjamin E Reubinoff, MD PhD","Chairman of Department of Obstetrics & Gynecology\u002FIVF, Hadassah Ein Kerem","PRINCIPAL_INVESTIGATOR",[18,22],{"name":14,"role":19,"phone":20,"phoneExt":10,"email":21},"CONTACT","011-972-2-6774569","benjaminr@ekmd.huji.ac.il",{"name":23,"role":19,"phone":24,"phoneExt":10,"email":25},"Shelly E. Tannenbaum, MSQA","011-972-2-572-2000","stannenbaum@hadassah.org.il",[27],{"facility":28,"status":29,"city":30,"state":31,"zip":32,"country":31,"countryCode":33,"cosmosGeoPoint":34,"geoPoint":39,"contacts":40},"Hadassah Ein Kerem","RECRUITING","Jerusalem","Israel","9112100","IL",{"type":35,"coordinates":36},"Point",[37,38],35.21633,31.76904,{"lat":38,"lon":37},[41,45],{"name":42,"role":19,"phone":43,"phoneExt":10,"email":44},"Benjamin E Reubinoff, Professor","972-2-6776424\u002F5","benr@hadassah.org.il",{"name":46,"role":19,"phone":47,"phoneExt":10,"email":25},"Shelly E Tannenbaum, MSQA","972-2-6775700",{"type":49,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100117941","use-of-existing-fibroblast-cells-to-convert-to-induced-pluripotent-stem-cells-100117941",false,"NCT00801372","Use of Existing Fibroblast Cells to Convert to Induced Pluripotent Stem Cells","Inclusion Criteria:\n\n* healthy, older than 18\n\nExclusion Criteria:\n\n* non healthy, younger than 18",true,"ALL","18 Years",{"count":60,"type":61},1,"ESTIMATED","OBSERVATIONAL","Induced pluripotent stem cells potentially may be useful in the future as an unlimited source of cells for transplantation.\n\nThe major goal of the project is to develop human iPS cells from existing lines of fibroblasts that were originally donated as clinical grade feeders for the development of clinical grade hESCs. The clinical grade feeders were developed from aborted fetuses, foreskin and umbilical cord.",[65,66],"Pregnant, Healthy Females","Healthy Male Newborns",[68,69,70],"termination of pregnancy","surgical circumcision","umbilical cord","2025-03-17",{"date":73,"type":74},"2025-03-19","ACTUAL",{"date":76,"type":74},"2008-11",{"date":78,"type":61},"2030-12",{"name":5,"class":6}]